Master Protocol of Sotorasib (AMG 510) in Subjects with Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreaK 101)

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-506794-35-00

Acronym

20190135

Enrollment

136

Registered

2024-09-11

Start date

2022-04-01

Completion date

Unknown

Last updated

2026-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Solid Tumors Kirsten Rat Sarcoma (KRAS) pG12C Mutation

None listed

Sex/Gender

All

Age

18 Years to No maximum

Austria, Belgium, Germany, Italy, Netherlands, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026